BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 12401721)

  • 1. Activation of cyclin D1-Cdk4 and Cdk4-directed phosphorylation of RB protein in diabetic mesangial hypertrophy.
    Féliers D; Frank MA; Riley DJ
    Diabetes; 2002 Nov; 51(11):3290-9. PubMed ID: 12401721
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A cyclin D1/cyclin-dependent kinase 4 binding site within the C domain of the retinoblastoma protein.
    Pan W; Cox S; Hoess RH; Grafström RH
    Cancer Res; 2001 Apr; 61(7):2885-91. PubMed ID: 11306463
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cyclin D1 is dispensable for G1 control in retinoblastoma gene-deficient cells independently of cdk4 activity.
    Lukas J; Bartkova J; Rohde M; Strauss M; Bartek J
    Mol Cell Biol; 1995 May; 15(5):2600-11. PubMed ID: 7739541
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multifaceted regulation of cell cycle progression by estrogen: regulation of Cdk inhibitors and Cdc25A independent of cyclin D1-Cdk4 function.
    Foster JS; Henley DC; Bukovsky A; Seth P; Wimalasena J
    Mol Cell Biol; 2001 Feb; 21(3):794-810. PubMed ID: 11154267
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cell cycle regulators in the neuronal death pathway of amyotrophic lateral sclerosis caused by mutant superoxide dismutase 1.
    Nguyen MD; Boudreau M; Kriz J; Couillard-Després S; Kaplan DR; Julien JP
    J Neurosci; 2003 Mar; 23(6):2131-40. PubMed ID: 12657672
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Critical role of cyclin D1 nuclear import in cardiomyocyte proliferation.
    Tamamori-Adachi M; Ito H; Sumrejkanchanakij P; Adachi S; Hiroe M; Shimizu M; Kawauchi J; Sunamori M; Marumo F; Kitajima S; Ikeda MA
    Circ Res; 2003 Jan; 92(1):e12-9. PubMed ID: 12522130
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biochemical characterizations reveal different properties between CDK4/cyclin D1 and CDK2/cyclin A.
    Kim DM; Yang K; Yang BS
    Exp Mol Med; 2003 Oct; 35(5):421-30. PubMed ID: 14646596
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rapamycin inhibits cdk4 activation, p 21(WAF1/CIP1) expression and G1-phase progression in transformed mouse fibroblasts.
    Gaben AM; Saucier C; Bedin M; Barbu V; Mester J
    Int J Cancer; 2004 Jan; 108(2):200-6. PubMed ID: 14639603
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The cyclin D1-dependent kinase associates with the pre-replication complex and modulates RB.MCM7 binding.
    Gladden AB; Diehl JA
    J Biol Chem; 2003 Mar; 278(11):9754-60. PubMed ID: 12519773
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of retinoblastoma protein phosphorylation by myogenesis-induced changes in the subunit composition of the cyclin-dependent kinase 4 complex.
    Wang J; Walsh K
    Cell Growth Differ; 1996 Nov; 7(11):1471-8. PubMed ID: 8930396
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cyclin D2 compensates for the loss of cyclin D1 in estrogen-induced mouse uterine epithelial cell proliferation.
    Chen B; Pollard JW
    Mol Endocrinol; 2003 Jul; 17(7):1368-81. PubMed ID: 12649329
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Defining the substrate specificity of cdk4 kinase-cyclin D1 complex.
    Grafstrom RH; Pan W; Hoess RH
    Carcinogenesis; 1999 Feb; 20(2):193-8. PubMed ID: 10069453
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inducible expression of cyclin D1 in T-47D human breast cancer cells is sufficient for Cdk2 activation and pRB hyperphosphorylation.
    Musgrove EA; Sarcevic B; Sutherland RL
    J Cell Biochem; 1996 Mar; 60(3):363-78. PubMed ID: 8867812
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Docking-dependent regulation of the Rb tumor suppressor protein by Cdk4.
    Wallace M; Ball KL
    Mol Cell Biol; 2004 Jun; 24(12):5606-19. PubMed ID: 15169919
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cell cycle-independent induction of D1 and D2 cyclin expression, but not cyclin-Cdk complex formation or Rb phosphorylation, by IFNgamma in macrophages.
    Dey A; Li W
    Biochim Biophys Acta; 2000 Jun; 1497(1):135-47. PubMed ID: 10838167
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cyclin D2 activates Cdk2 in preference to Cdk4 in human breast epithelial cells.
    Sweeney KJ; Sarcevic B; Sutherland RL; Musgrove EA
    Oncogene; 1997 Mar; 14(11):1329-40. PubMed ID: 9178893
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High glucose stimulates expression of p27Kip1 in cultured mouse mesangial cells: relationship to hypertrophy.
    Wolf G; Schroeder R; Ziyadeh FN; Thaiss F; Zahner G; Stahl RA
    Am J Physiol; 1997 Sep; 273(3 Pt 2):F348-56. PubMed ID: 9321907
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential requirements for ras and the retinoblastoma tumor suppressor protein in the androgen dependence of prostatic adenocarcinoma cells.
    Fribourg AF; Knudsen KE; Strobeck MW; Lindhorst CM; Knudsen ES
    Cell Growth Differ; 2000 Jul; 11(7):361-72. PubMed ID: 10939590
    [TBL] [Abstract][Full Text] [Related]  

  • 19. YC-1-inhibited proliferation of rat mesangial cells through suppression of cyclin D1-independent of cGMP pathway and partially reversed by p38 MAPK inhibitor.
    Chiang WC; Teng CM; Lin SL; Chen YM; Tsai TJ; Hsieh BS
    Eur J Pharmacol; 2005 Jul; 517(1-2):1-10. PubMed ID: 15950964
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Loss of p27Kip1 from cyclin E/cyclin-dependent kinase (CDK) 2 but not from cyclin D1/CDK4 complexes in cells transformed by polyamine biosynthetic enzymes.
    Ravanko K; Järvinen K; Paasinen-Sohns A; Hölttä E
    Cancer Res; 2000 Sep; 60(18):5244-53. PubMed ID: 11016654
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.